이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Stericycle 미래 성장

Future 기준 확인 4/6

Stericycle (는) 각각 연간 39.9% 및 4.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 40.7% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 11.5% 로 예상됩니다.

주요 정보

38.9%

수익 성장률

39.7%

EPS 성장률

Commercial Services 수익 성장	13.9%
매출 성장률	4.2%
향후 자기자본 수익률	11.5%
애널리스트 커버리지	Good
마지막 업데이트	06 Sep 2024

최근 미래 성장 업데이트

Recent updates

수익 및 매출 성장 예측

LSE:0L9O - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	2,939	306	328	471	3
12/31/2025	2,793	178	257	406	8
12/31/2024	2,695	99	195	345	8
6/30/2024	2,632	36	-69	78	N/A
3/31/2024	2,640	-19	1	139	N/A
12/31/2023	2,659	-21	112	243	N/A
9/30/2023	2,678	-4	222	350	N/A
6/30/2023	2,715	22	248	374	N/A
3/31/2023	2,725	81	157	289	N/A
12/31/2022	2,705	56	68	200	N/A
9/30/2022	2,692	7	7	144	N/A
6/30/2022	2,650	-87	8	135	N/A
3/31/2022	2,643	-68	72	202	N/A
12/31/2021	2,647	-28	186	303	N/A
9/30/2021	2,646	38	257	367	N/A
6/30/2021	2,633	23	368	473	N/A
3/31/2021	2,559	-11	406	511	N/A
12/31/2020	2,676	-57	411	530	N/A
9/30/2020	2,820	-325	284	412	N/A
6/30/2020	3,016	-303	224	384	N/A
3/31/2020	3,264	-329	126	294	N/A
12/31/2019	3,309	-347	54	248	N/A
9/30/2019	3,362	-446	82	277	N/A
6/30/2019	3,384	-369	-169	6	N/A
3/31/2019	3,421	-312	-77	92	N/A
12/31/2018	3,486	-253	35	166	N/A
9/30/2018	3,521	148	58	207	N/A
6/30/2018	3,549	166	357	501	N/A
3/31/2018	3,583	-9	N/A	451	N/A
12/31/2017	3,581	23	N/A	509	N/A
9/30/2017	3,599	-47	N/A	535	N/A
6/30/2017	3,607	-21	N/A	554	N/A
3/31/2017	3,581	165	N/A	572	N/A
12/31/2016	3,562	178	N/A	561	N/A
9/30/2016	3,544	236	N/A	515	N/A
6/30/2016	3,373	244	N/A	457	N/A
3/31/2016	3,197	295	N/A	415	N/A
12/31/2015	2,986	257	N/A	386	N/A
9/30/2015	2,775	269	N/A	397	N/A
6/30/2015	2,724	282	N/A	389	N/A
3/31/2015	2,649	276	N/A	435	N/A
12/31/2014	2,556	326	N/A	449	N/A
9/30/2014	2,447	322	N/A	414	N/A
6/30/2014	2,313	320	N/A	467	N/A
3/31/2014	2,199	316	N/A	453	N/A
12/31/2013	2,143	311	N/A	405	N/A
9/30/2013	2,079	303	N/A	446	N/A

애널리스트 미래 성장 예측

수입 대 저축률: 0L9O 의 연간 예상 수익 증가율( 39.9% )이 saving rate( 1.9% 보다 높습니다. ).

수익 vs 시장: 0L9O 의 연간 수익( 37.7% ) UK 시장( 12.8% 보다 빠르게 성장할 것으로 예상됩니다. 12.8% 연간).

고성장 수익: 0L9O 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: 0L9O 의 수익(연간 4.3% ) UK 시장( 3.7% 보다 빠르게 성장할 것으로 예상됩니다. 3.7% 연간).

고성장 수익: 0L9O 의 수익(연간 4.3% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 0L9O 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 11.1 %).

Stericycle 미래 성장

Future 기준 확인 4/6

주요 정보

최근 미래 성장 업데이트

Stericycle, Inc. Provides Earnings Guidance for the Full-Year 2022

Recent updates

Second quarter 2024 earnings released: EPS: US$0.065 (vs US$0.54 loss in 2Q 2023)

Waste Management, Inc. (NYSE:WM) entered into an Agreement and Plan of Merger to acquire Stericycle, Inc. (NasdaqGS:SRCL) for $5.8 billion.

New minor risk - Share price stability

First quarter 2024 earnings released: EPS: US$0.14 (vs US$0.12 in 1Q 2023)

Stericycle, Inc., Annual General Meeting, May 21, 2024

Full year 2023 earnings released: US$0.23 loss per share (vs US$0.61 profit in FY 2022)

New major risk - Financial position

Third quarter 2023 earnings released: EPS: US$0.022 (vs US$0.30 in 3Q 2022)

Stericycle, Inc. Reports Impairment Changes for the Second Quarter Ended June 30, 2023

Second quarter 2023 earnings released: US$0.54 loss per share (vs US$0.11 profit in 2Q 2022)

Enviri Corporation Reaches an Amicable Agreement with Stericycle, Inc

Executive VP & Chief People Officer recently bought US$309k worth of stock

Stericycle, Inc. Approves the Election of Victoria L. Dolan as Director

First quarter 2023 earnings released: EPS: US$0.12 (vs US$0.15 loss in 1Q 2022)

Director recently bought US$287k worth of stock

Full year 2022 earnings released: EPS: US$0.61 (vs US$0.30 loss in FY 2021)

Now 24% undervalued

Insufficient new directors

Stericycle, Inc. Appoints Naren K. Gursahaney to the Board of Directors, Effective January 1, 2023

Insufficient new directors

Infomedia Group, Inc. acquired Stericycle Communication Solutions, Inc. from Stericycle, Inc. (NasdaqGS:SRCL) for $45 million.

Insufficient new directors

Second quarter 2022 earnings released: EPS: US$0.11 (vs US$0.32 in 2Q 2021)

Insufficient new directors

Insufficient new directors

First quarter 2022 earnings released: US$0.15 loss per share (vs US$0.28 profit in 1Q 2021)

Stericycle, Inc., Annual General Meeting, May 26, 2022

Stericycle, Inc. Announces New Safeshield™ Medical Waste Containers

High number of new directors

Stericycle, Inc. Provides Earnings Guidance for the Full-Year 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

High number of new directors

High number of new directors

Third quarter 2021 earnings released: US$0.72 loss per share (vs US$0.89 loss in 3Q 2020)

High number of new directors

Second quarter 2021 earnings released: EPS US$0.32 (vs US$0.049 loss in 2Q 2020)

High number of new directors

First quarter 2021 earnings released: EPS US$0.28 (vs US$0.22 loss in 1Q 2020)

Full year 2020 earnings released: US$0.63 loss per share (vs US$3.81 loss in FY 2019)

Revenue beats expectations

Stericycle, Inc.(NasdaqGS:SRCL) dropped from FTSE All-World Index (USD)

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견